[Heart arrhythmias and congestive heart failure].

Along with the successful pharmacotherapic achievements in patients with congestive heart failure survival rate in this category of patients still remains unfavourable. Many antiarrhythmic drugs that cause proarrhythmic effect in patients with congestive heart failure, are characterized by narrow therapeutic window of action and their metabolism is usually changed. Patients with ventricular arrhythmias and disturbances of left ventricular function belong to group with elevated risk of sudden death and complex ventricular impairments are predictors of lethal outcome.

[Optimal approach to the treatment of atrial fibrillation in patients with chronic heart failure].

Atrial fibrillation (AF) is one of the most frequently seen arrhythmia. Optimal strategy of its treatment still remains a serious problem. The goal of the investigation was the evaluation of the efficacy of combined treatment of AF with Cordaron and ACE inhibitor Diroton (lizinopril) (D) in patients with chronic heart failure (CHF).